Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial
08.31.2020 - By ESC Cardio Talk
With Renato Lopes, Duke Univ. Medical Center - U.S. and Alexander Fanaroff, Univ. of Pennsylvania - U.S.
Link to EHJ paper: https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaa617/5898835?